Alzheimer's with Agitation: Many individuals who suffer from Alzheimer's also suffer from agitation. According to the NIH, agitation means that a person is restless or worried; he or she doesn’t seem to be able to settle down. Agitation may cause pacing and sleeplessness. In two of our current studies, different medications are being tested to ease the symptoms of agitation. For more information on this trial, click here.
What to Expect?
First, a consultation visit to assess eligibility and ensure your interest in participation.
Participation will include taking a medication on a daily basis and regular site study visits.
Study visits consist of psychiatric and physical evaluations, along with vital assessments such as EKG, blood pressure, and laboratory tests.
Medication and care related to research will not be charged.
Families will be compensated for their time and travel.
To learn more about participation, please call (734) 800 - 5848 or fill out the fields below.
*Disclosure: Dr. Rajarethinam, the Principal Investigator, conducts contract research for various pharmaceutical companies, including: Johnson & Johnson, Neurocrine, Otsuka, Astellas, Jansson, and a variety of others. He also participates in promotional meetings for Neurocrine Sciences.